Article - International Biopharmaceutical Industry
Published: Jul 28, 2020

Head of Clinical Development, Dr. Brian Roberts - Congential Hyperinsulinism Treatment Gaps and a Potential Solution

Interview: The Rare Daily
Published: Jun 11, 2020

CEO Nevan Elam with Global Genes' Marie Daghlian - Rezolute Gains Rare Pediatric Disease Designation for RZ358 in Congenital Hyperinsulinism

Interview: Empowered Patient Podcast
Published: Feb 3, 2020

CEO Nevan Elam with Karen Jagoda - Developing Therapeutics for Rare Pediatric Diseases 

Nature's BioPharma Dealmakers
Published: Nov 1, 2019

Nature Biotechnology, and Nature Reviews Drug Discovery, November 2019 edition

Interview: Proactive Investors
Published: Oct 22, 2019

CFO Keith Vendola speaks with Proactive's Christine Corrado at the 2019 BIO Investor Forum Conference